Pharmacists on the temporary register will be automatically removed on April 1, unless they have applied to rejoin the permanent register, the General
Pharmaceutical Council has said.
The government asked the GPhC and other pertinent health professional regulators to close temporary registers by March 31, 2024.
According to the GPhC, this decision is based on the anticipation that the emergency conditions justifying the establishment of these temporary registers will
cease after the approaching winter.
The temporary register was established after the Health and Social Care Secretary asked the Council to utilise its emergency powers to swiftly register pharmacy
professionals for their essential role in the national COVID-19 response.
Pharmacists and pharmacy technicians who had previously opted to withdraw from the GPhC register or failed to renew their registration are now eligible for
immediate re-registration, the regulator added.
New amendments to the Human Medicines Regulations will soon allow registered pharmacy technicians to supply and administer medicines under Patient Group
Directions (PGDs).
Laid before Parliament at the end of May, the legislative changes will come into effect from June 26, 2024, the Community Pharmacy England (CPE) announced today.
The introduction of this new legislation follows an announcement made by the Department of Health and Social Care (DHSC) earlier this year.
The regulatory adjustments provide the legal framework for pharmacy technicians to engage in the supply and administration of medicines under PGDs in the course
of their professional practice. However, there will be no immediate change in the provision of community pharmacy services, the CPE noted
The General Pharmaceutical Council (GPhC) will launch a new group focusing on improvement of the post-registration practice of pharmacists and pharmacy technicians.
The announcement follows GPhC and Pharmaceutical Society of Northern Ireland (PSNI) bringing together key stakeholders from across England, Scotland, Wales and
Northern Ireland on Thursday (January 27) to discuss establishment of the group.
The GPhC considered recommendations from a short-life working group chaired by Council member Aamer Safdar on the potential leadership and quality assurance role of the GPhC in post-registration education and training for pharmacists and pharmacy technicians.
Nigel Clarke, chair of the GPhC noted that there is a wide range of activity in the post-registration sphere with government and statutory education providers taking steps to make improvement.
The government has extended VAT exemption from Monday (1 May) on healthcare services carried out by pharmacy staff under the supervision of pharmacists.
HM Revenue and Customs has issued a note detailing the change to the VAT treatment of medical services. The Government said this will bring the VAT treatment of
pharmacists in line with other registered health professionals providing medical services to the public.
The Pharmaceutical Services Negotiating Committee (PSNC) said: "This is something that PSNC has been seeking Government agreement on for a long time, including in
recent CPCF negotiations."
PSNC believes that the extension of this VAT exemption will help as community pharmacy businesses try to make better use of the skill mix in their teams both now
and in the future.
"Not only does it enable contractors to review the VAT status of any locally commissioned services currently provided by non-registered pharmacy staff but also, in
time, it could be used to amend nationally commissioned services to allow support staff to provide certain parts. For example, following a recent amendment to the
service Directions, pharmacy technicians are now able to perform blood pressure checks as part of the Hypertension Case-Finding Service and deliver the Smoking
Cessation Service.
The General Pharmaceutical Council (GPhC) has alerted pharmacists, pharmacy technicians, and pharmacy owners via email regarding new emergency legislation
governing the prescribing and supply of puberty-suppressing hormones, commonly known as 'puberty blockers', for children and young people under 18 in England,
Wales, and Scotland.
The regulations apply to gonadotropin-releasing hormone (GnRH) analogues, used to suppress puberty as part of treating gender incongruence or gender dysphoria in
individuals under 18.
Effective from 3 June 2024, new private prescriptions for GnRH analogues from prescribers in the European Economic Area (EEA) or Switzerland who are not UK
registered are banned from being dispensed in Great Britain for patients under 18.
The emergency ban on these medicines will remain in effect until September 3, 2024, the Department of Health and Social Care (DHSC) announced on 29 May, stating
that the action has been taken to address risks to "patient safety."
The Pharmaceutical Society NI (PSNI)'s Council has decided to freeze the annual registration fee for the current financial year 2023/24.
The annual registration fee is considered each year by the PSNI's council. At its meeting in November 2022, Council members in recognition of the effects of the
Covid-19 pandemic, the personal and professional impact of the cost of living crisis on pharmacists, and the overall cost of regulation agreed to maintain
registration fees at their current level for the next financial year.
Pharmaceutical Society NI's Chief Executive Michaela McAleer said: "I am pleased with Council's decision to continue the freeze on registration fees for the 7th
successive year. We are acutely aware of the pressures facing the pharmacy profession and hope this can provide some reassurance to the profession as we deal with
these financially difficult times.